⌘K

Login Start Free

Home/Filings/4/0001348362-25-000013

4//SEC Filing

Carle Vanessa 4

Accession 0001348362-25-000013

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 11:23 AM ET

Size

13.1 KB

Accession

0001348362-25-000013

Insider Transaction Report

Form 4

Period: 2025-07-29

Lexaria Bioscience Corp.LEXX

Secretary

Transactions

Purchase
common shares
2025-07-29$0.91/sh+750$683→ 750 total

Holdings

Stock Options
Exercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (15,000 underlying)
75,000
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (10,000 underlying)
27,500
Stock Options
Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (12,500 underlying)
40,000
Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying)
17,500
Stock Options
Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (10,000 underlying)
60,000
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (12,500 underlying)
12,500
Stock Options
Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (10,000 underlying)
50,000

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001855763

Filing Metadata

Form type: 4
Filed: Jul 29, 8:00 PM ET
Accepted: Jul 30, 11:23 AM ET
Size: 13.1 KB

View on SEC.gov